SpectraLIT, a Compact Development Kit for Spectral Analysis Applications Introduced by Newsight Imaging

Accolade to Acquire PlushCare

Accolade to begin offering virtual primary care and mental health consultations directly to members as a result of the acquisition.

CareDx to Present New Heart Transplant Data at the International Society for Heart and Lung Transplantation Annual Meeting

Experts will present its latest heart research, which was accepted at the International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, set to take place between April 24-28, 2021.

Dermatology Experts Present Latest Information at AAD VMX 2021

The AAD VMX 2021, a virtual meeting experience taking place April 23-25, will feature the latest information on skin, hair, and nails, presented by world-renowned experts in the field of dermatology.

June 12, 2020

Newsight Imaging, the CMOS image sensor chip maker for 3D machine vision and spectral analysis applications announced the release of its SpectraLIT, a compact development kit suitable for testing Newsight technology and developing proof-of-concept devices for the healthcare and food & beverage industries or other liquids analysis.

SpectraLIT™ is a development kit based on Newsight’s spectrometer-on- chip. It allows for spectral profiling of substances in wavelengths between 400 to 700 nm in a matter of seconds. The next generation of SpectraLIT™️ will be able to support wavelengths between 400 to 1100 nm. The kit will allow diagnostic and analytical companies a fast market introduction of a portable, and low-cost diagnosis device. SpectraLIT is controlled by a Windows-based demo SW that displays, analyzes and stores the spectral profiles of the tested substance.

SpectraLIT uses standard cuvettes, which are easily inserted through a slide covered by a top lid, allowing full isolation of the tested substance from any external ambient light.

Using a special developed algorithm, SpectraLIT can compare the tested substance’s spectral profiles to profiles stored in a local database, allowing detection and identification of matching substances previously analyzed by SpectraLIT.

Newsight is now offering its potential partners to develop its POC based on SpectraLIT™. Upon achieving successful implementation, Newsight is offering its partner to license the technology, acquire the spectral chips or use a ready-made module to build their own game changing device.

On June 16th, 16:00 pm CEST, Newsight will conduct a free live webinar demonstrating SpectraLIT™ for potential future partners who will be interested in building an immediate, portable, and affordable detection device based on spectral profiling technology. To register here.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine

Related Articles